GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » Shares Buyback Ratio %

Shandong Sito Bio-technology Co (SZSE:300583) Shares Buyback Ratio % : 0.00 (As of May. 21, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Shandong Sito Bio-technology Co's current shares buyback ratio was 0.00%.


Shandong Sito Bio-technology Co Shares Buyback Ratio % Historical Data

The historical data trend for Shandong Sito Bio-technology Co's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co Shares Buyback Ratio % Chart

Shandong Sito Bio-technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.19 0.31 -10.89 -

Shandong Sito Bio-technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shandong Sito Bio-technology Co Shares Buyback Ratio % Calculation

Shandong Sito Bio-technology Co's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(189.702 - 189.702) / 189.702
=0.00%

Shandong Sito Bio-technology Co's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Mar. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(189.702 - 189.702) / 189.702
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Sito Bio-technology Co Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Shandong Sito Bio-technology Co's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sito Bio-technology Co Business Description

Traded in Other Exchanges
N/A
Address
South Section of East Outer Ring Road, Dingtao District, Shandong Province, Heze, CHN, 274100
Shandong Sito Bio-technology Co Ltd is a biotechnology company. It uses genetic engineering technology and microbial transformation technology to develop and produce steroid drug raw materials, specialty respiratory raw materials and finished preparations, and other drug intermediaries. The company operates in the following business segments; intermediates, high-end specialty respiratory APIs, and preparations. Its product offerings include androstenedione (AD), 9-hydroxy androstenedione (90H-AD), 17a-hydroxyprogesterone derivatives (A ring), and bi-decanoic acid (BA), and others. In addition, the company holds patents for various APIs and other intermediaries.
Executives
Mi Qi Directors, executives
Wang Min Director
Kong Qing Zhi Executives
He Jian Yong Directors, executives
Ceng Qing Li Securities Affairs Representative

Shandong Sito Bio-technology Co Headlines

No Headlines